77523-98-9

Basic information

• Product Name: 1-(1H-benzimidazol-2-ylmethyl)-3-benzylthiourea
• CAS NO: 77523-98-9
• Molecular Formula: C₁₆H₁₆N₄S
• Molecular Weight: 296.39
• Mol File: 77523-98-9.mol
• Article Data: 2

Chemical Properties

• Boiling Point: 542.2°C at 760 mmHg
• Flash Point: 281.7°C
• Density: 1.301g/cm³
• Vapor Pressure: 8.07E-12mmHg at 25°C
• Refractive Index: 1.718
• CAS DataBase Reference: 1-(1H-benzimidazol-2-ylmethyl)-3-benzylthiourea(CAS DataBase Reference)
• NIST Chemistry Reference: 1-(1H-benzimidazol-2-ylmethyl)-3-benzylthiourea(77523-98-9)
• EPA Substance Registry System: 1-(1H-benzimidazol-2-ylmethyl)-3-benzylthiourea(77523-98-9)

Safety Data

• Hazardous Substances Data: 77523-98-9(Hazardous Substances Data)

Usage

Description

1-(1H-benzimidazol-2-ylmethyl)-3-benzylthiourea is a chemical compound belonging to the thiourea family, characterized by the presence of both benzimidazole and benzylthiourea moieties. It has been investigated for its potential antitumor and anticancer properties, as well as its ability to inhibit the growth of cancer cells. 1-(1H-benzimidazol-2-ylmethyl)-3-benzylthiourea also shows promise as a potential treatment for various diseases and conditions, such as diabetes and inflammation. Its unique structure makes it an intriguing candidate for further research into its pharmaceutical applications.

Uses

Used in Pharmaceutical Industry:
1-(1H-benzimidazol-2-ylmethyl)-3-benzylthiourea is used as a potential antitumor and anticancer agent due to its demonstrated ability to inhibit the growth of cancer cells. It is particularly promising for its potential to treat various types of cancer, given its biological activities.
Used in Medical Research:
1-(1H-benzimidazol-2-ylmethyl)-3-benzylthiourea is used as a subject of study in the field of medical research, where it is being explored for its potential applications in treating diseases and conditions such as diabetes and inflammation, in addition to its antitumor and anticancer properties.
Used in Drug Development:
1-(1H-benzimidazol-2-ylmethyl)-3-benzylthiourea is utilized in drug development as a lead compound for the creation of new pharmaceuticals targeting cancer and other diseases. Its unique structure and biological activities make it a valuable starting point for the design and synthesis of novel therapeutic agents.

Upstream product

• 5805-57-2 2-Aminomethylbenzimidazole 
• 622-78-6 Benzyl isothiocyanate 
• 5993-91-9 2-(aminomethyl)benzimidazole dihydrochloride 

Downstream Products

• 77524-07-3 (3H-Benzo[d]imidazo[1,5-a]imidazol-1-yl)-benzyl-amine 
• 108784-90-3 3-benzimidazol-2-ylmethyl-2-benzylimino-2,3-dihydrothiazol-4-(5H)-one 

Relevant articles and documents

Syntheses and in vitro antimicrobial evaluation of some benzimidazol-2-ylmethylthioureas, benzimidazol-2-ylacetylthiosemicarbazides and products of their condensation with monochloroacetic acid

-